You are here:

MS in the media - 13 May 2016

Published on

7 - 13 May 2016

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

Long-term use of disease modifying drugs

A study found that people with relapsing MS who had stayed on disease modifying drug treatment longest over a ten year period had lower EDSS scores than people on shorter or no treatment.

Source: Doctors' Lounge

MS Trust link: MS Decisions - a guide to disease modifying drugs

Symptoms during relapses

A study found that relapses involving several symptoms were a marker of potential increases in disability, measured by EDSS, than single symptom relapses.  Similarly bowel and bladder, cerebellar (ataxia/tremor) and pyramidal (weakness/muscle movement) symptoms in relapse suggested increase in disability

Source: Neurology Advisor

MS Trust link: Relapse

The potential of ocrelizumab

A review of ocrelizumab, written for investors, and the potential of the drug as a future treatment for relapsing and progressive MS

Source: Motley Fool

MS Trust link: Ocrelizumab

AAN meeting round up

 A review of topics covered by last month's American Academy of Neurology (AAN) meeting.  Includes biotin, lipoic acid, misdiagnosis with MS, academic performance of children of people with MS, salt, myelin repair, self-repair mechanisms stem cell therapy, hormone replacement, cognition, treadmill exercise and genes

Source: National MS Society (USA)

MS Trust link: MS in the media - AAN 2016


Diet and inflammation in the brain

American research says that gut bacteria affect cells in the brain which have a role in inflammation and neurodegeneration.  The research has been in mice and with blood samples from people with MS.

Source: Science Daily
Source: National MS Society (USA)
Source: Daily Mail

MS Trust link: Diet

Cancer risk and MS

A study found that, although people with MS tend to have lower rates of most cancers, the rate for young-adult onset Hodgkin lymphoma (YAHL) was higher than for people who don't have MS.  Suggestion that there might be a common trigger in the Epstein Barr virus

MS Trust link: MS research update - Overall cancer risk is lower in people with MS

Mitoxantrone and cancer risk

A study found that, compared to the general population, people with MS taking mitoxantrone had a three times higher risk of colorectal cancer and a ten times higher risk of acute myeloid leukaemia.  Risk of breast cancer was unchanged

Source: Medical News Today
Source: Science Daily

MS Trust link: Mitoxantrone

Carers and the Care Act

A report of a survey by Carers UK found that the benefits of the Care Act were not being felt by many people caring for a relative or friend.  The number of people who felt their quality of life was likely to get worse in the coming year had gone up slightly since the introduction of the Act

Source: BBC

MS Trust link: Carers

Palliative care services patchy

A study of palliative care in the UK found wide variation in how services were coordinated with neurological services and that services for people with MS had the least integration.

Source: MD Magazine

MS Trust link: Palliative care
MS Trust link: Let's make MS care fair

Print this page